Harvard Bioscience
HBIOHarvard Bioscience is a global developer and manufacturer of specialized technologies and services that support life science research, drug discovery, and preclinical testing.
Table of contents
Earnings
Next report
Aug 10, 2026 (In 4 weeks)Competitors
By market cap
By revenue growth
Profile
Harvard Bioscience is a global developer and manufacturer of specialized technologies and services that support life science research, drug discovery, and preclinical testing. The company provides a broad range of instruments, software, and consumables used by scientists to advance molecular, cellular, and organ-level studies. Its core value proposition lies in bridging the gap between laboratory research and human clinical success through high-performance tools for translational medicine.
A leading provider of gold-standard preclinical tools and cellular research technologies, currently transitioning from a traditional tools provider to an enabler of translational medicine.
Questions, answered.
- What is Harvard Bioscience's market cap?
- Harvard Bioscience (HBIO) has a market capitalization of $28.1M and trades on NASDAQ.
- Who are Harvard Bioscience's competitors?
- Harvard Bioscience's key competitors include Revvity, Inc., Danaher Corporation, Agilent Technologies, and others. These companies compete in similar markets and product categories.
- Who does Harvard Bioscience partner with?
- Harvard Bioscience's notable partners include Harvard University.
- What subsidiaries does Harvard Bioscience have?
- Harvard Bioscience's subsidiaries include Data Sciences International, Inc..
- Where is Harvard Bioscience headquartered?
- Harvard Bioscience is headquartered in United States of America and employs approximately 416 people. It has been publicly traded since 2000.